PTX Media related, page-1351

thanks for the share cash!
well it sounds like we are still committed to the autologous cell type, therefore I am still holding hope for Omnicar to hit clinical trials this year.

What really perked my ears up was when Steven mentioned that they were extremely close to Omnicar deals prior to the market meltdown. If most of the groundwork is done, perhaps in the not too distant future we could see collaborations? As the CAR-T therapy space heats up, companies will look to get the edge over their competitors. This is where Omnicar and Cellpryme could position prescient very well moving forward.

just need the domino’s to start to fall, at the moment it’s just the share price